Clinical Trials in Tennessee

Showing 11041-11060 of 20,239 trials

Study of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Type I or II Achalasia

NCT02931565

The objectives of this study are as follows: In participants with primary Type I or II achalasia, following a single 5-mg dose of olinciguat (IW-1701), * To assess the safety and tolerability * To determine the effects on measures of esophageal function by high-resolution impedance manometry (HRIM) * To determine the pharmacokinetic (PK) parameters

Achalasia

Cyclerion Therapeutics9 participantsStarted Apr 2017

Bristol, Connecticut, United States • Rochester, Minnesota, United States • St Louis, Missouri, United States +2 more locations

COMPLETEDPhase 229 miles

Safety and Tolerability Study of NBI-98854 for the Treatment of Subjects With Tourette Syndrome

NCT02879578

Phase 2, open-label, fixed-dose titration study to evaluate the safety and tolerability of NBI-98854 administered once daily for a total of 24 weeks in children, adolescents, and adults with Tourette Syndrome (TS).

Tourette Syndrome

Neurocrine Biosciences155 participantsStarted Jul 2016

Sun City, Arizona, United States • San Diego, California, United States • Loxahatchee Groves, Florida, United States +10 more locations

COMPLETEDPhase 229 miles

BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence

NCT03861936

Based on the results of the Phase 2 Study 191622-130 \[NCT02010775\], the current Phase 2b study is designed to further evaluate the safety and efficacy of BOTOX® for the treatment of Masseter Muscle Prominence (MMP) in adults.

Masseter Muscle Prominence

Allergan150 participantsStarted May 2019

Birmingham, Alabama, United States • Los Angeles, California, United States • Los Angeles, California, United States +11 more locations

Study of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Type I or II Achalasia

Safety and Tolerability Study of NBI-98854 for the Treatment of Subjects With Tourette Syndrome

BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence

Find Trials by Condition in Tennessee

Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2

SOFI: A Quality Improvement Project to Standardize Use of Intravenous Fluids in Hospitalized Pediatric Patients

Age of Blood in Children in Pediatric Intensive Care Units

Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.

Multi-center:The Small (14F) Percutaneous Catheter vs. Large (28-40F) Open Chest Tube for Traumatic Hemothorax (P-CAT)

A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression

A Safety and Efficacy Study of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy

Bio-equivalence Study Between SAPHRIS and Asenapine

Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder

H1N1v Virus Challenge Study in Healthy Subjects

Trial of High-dose Urso in Primary Sclerosing Cholangitis

Study of Safety and Efficacy of Avadomide (CC-122) Combined With RCHOP for Newly-diagnosed DLBCL With Poor Risk Factors

Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML

Enhanced Protein-Energy Provision Via the Enteral Route in Critically Ill Patients

Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian Cancer

Comparison of the ToFscan and TetraGraph During Recovery of Neuromuscular Function in the Post Anesthesia Care Unit

Global Anticoagulant Registry in the Field